 | • レポートコード：MRC2Q12-19387 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、128ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、組換えタンパク質発現システムのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 組換えタンパク質発現システムのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 組換えタンパク質発現システムの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 組換えタンパク質発現システムのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの組換えタンパク質発現システムの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の組換えタンパク質発現システムの売上および2028年までの予測に焦点を当てています。 組換えタンパク質発現システムのグローバル主要企業には、Thermo Fisher、Merck、GenScript、Agilent、Takara Bio、Bio-Rad Laboratories、Qiagen N.V、Charles River、Sartorius、Corning、FUJIFILM Irvine Scientific、Lonza Group、Bioneer Corporation、Promega、Oxford Expression Technologies、ProteoGenix、Abeomics、New England Biolabs、Promab Biotechnologies、Sino Biological、Jena Bioscience、Lifesensors、Leading biology、Peak Proteinsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 組換えタンパク質発現システム市場は、タイプとアプリケーションによって区分されます。世界の組換えタンパク質発現システム市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 哺乳類細胞発現系、原核細胞発現系、昆虫細胞発現系、酵母発現系、無細胞発現系、藻類系発現系 【アプリケーション別セグメント】 製薬会社、研究機関、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 組換えタンパク質発現システム製品概要 - タイプ別市場（哺乳類細胞発現系、原核細胞発現系、昆虫細胞発現系、酵母発現系、無細胞発現系、藻類系発現系） - アプリケーション別市場（製薬会社、研究機関、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の組換えタンパク質発現システム販売量予測2017-2028 - 世界の組換えタンパク質発現システム売上予測2017-2028 - 組換えタンパク質発現システムの地域別販売量 - 組換えタンパク質発現システムの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別組換えタンパク質発現システム販売量 - 主要メーカー別組換えタンパク質発現システム売上 - 主要メーカー別組換えタンパク質発現システム価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（哺乳類細胞発現系、原核細胞発現系、昆虫細胞発現系、酵母発現系、無細胞発現系、藻類系発現系） - 組換えタンパク質発現システムのタイプ別販売量 - 組換えタンパク質発現システムのタイプ別売上 - 組換えタンパク質発現システムのタイプ別価格 ・アプリケーション別市場規模（製薬会社、研究機関、その他） - 組換えタンパク質発現システムのアプリケーション別販売量 - 組換えタンパク質発現システムのアプリケーション別売上 - 組換えタンパク質発現システムのアプリケーション別価格 ・北米市場 - 北米の組換えタンパク質発現システム市場規模（タイプ別、アプリケーション別） - 主要国別の組換えタンパク質発現システム市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの組換えタンパク質発現システム市場規模（タイプ別、アプリケーション別） - 主要国別の組換えタンパク質発現システム市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の組換えタンパク質発現システム市場規模（タイプ別、アプリケーション別） - 主要国別の組換えタンパク質発現システム市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の組換えタンパク質発現システム市場規模（タイプ別、アプリケーション別） - 主要国別の組換えタンパク質発現システム市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの組換えタンパク質発現システム市場規模（タイプ別、アプリケーション別） - 主要国別の組換えタンパク質発現システム市場規模（トルコ、サウジアラビア） ・企業情報 Thermo Fisher、Merck、GenScript、Agilent、Takara Bio、Bio-Rad Laboratories、Qiagen N.V、Charles River、Sartorius、Corning、FUJIFILM Irvine Scientific、Lonza Group、Bioneer Corporation、Promega、Oxford Expression Technologies、ProteoGenix、Abeomics、New England Biolabs、Promab Biotechnologies、Sino Biological、Jena Bioscience、Lifesensors、Leading biology、Peak Proteins ・産業チェーン及び販売チャネル分析 - 組換えタンパク質発現システムの産業チェーン分析 - 組換えタンパク質発現システムの原材料 - 組換えタンパク質発現システムの生産プロセス - 組換えタンパク質発現システムの販売及びマーケティング - 組換えタンパク質発現システムの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 組換えタンパク質発現システムの産業動向 - 組換えタンパク質発現システムのマーケットドライバー - 組換えタンパク質発現システムの課題 - 組換えタンパク質発現システムの阻害要因 ・主な調査結果 |
Proteins produced from such DNA templates are called recombinant proteins. Traditional strategies for recombinant protein expression involve transfecting cells with a DNA vector that contains the template and then culturing the cells so that they transcribe and translate the desired protein.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Recombinant Protein Expression System estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Recombinant Protein Expression System is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Recombinant Protein Expression System is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Recombinant Protein Expression System is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Recombinant Protein Expression System include Thermo Fisher, Merck, GenScript, Agilent, Takara Bio, Bio-Rad Laboratories, Qiagen N.V, Charles River and Sartorius, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Recombinant Protein Expression System companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Recombinant Protein Expression System market. Further, it explains the major drivers and regional dynamics of the global Recombinant Protein Expression System market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Thermo Fisher
Merck
GenScript
Agilent
Takara Bio
Bio-Rad Laboratories
Qiagen N.V
Charles River
Sartorius
Corning
FUJIFILM Irvine Scientific
Lonza Group
Bioneer Corporation
Promega
Oxford Expression Technologies
ProteoGenix
Abeomics
New England Biolabs
Promab Biotechnologies
Sino Biological
Jena Bioscience
Lifesensors
Leading biology
Peak Proteins
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Recombinant Protein Expression System Segment by Type
Mammalian Cell Expression System
Prokaryotic Expression System
Insect Cell Expression System
Yeast Expression System
Cell-free Expression System
Algal-based Expression System
Recombinant Protein Expression System Segment by Application
Pharmaceutical Companies
Research Institutes
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Recombinant Protein Expression System market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Recombinant Protein Expression System market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Recombinant Protein Expression System, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Recombinant Protein Expression System, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Recombinant Protein Expression System revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Recombinant Protein Expression System market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Recombinant Protein Expression System revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Thermo Fisher, Merck, GenScript, Agilent, Takara Bio, Bio-Rad Laboratories, Qiagen N.V, Charles River and Sartorius, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Recombinant Protein Expression System in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Recombinant Protein Expression System companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Recombinant Protein Expression System revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Recombinant Protein Expression System Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Mammalian Cell Expression System
1.2.3 Prokaryotic Expression System
1.2.4 Insect Cell Expression System
1.2.5 Yeast Expression System
1.2.6 Cell-free Expression System
1.2.7 Algal-based Expression System
1.3 Market by Application
1.3.1 Global Recombinant Protein Expression System Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Pharmaceutical Companies
1.3.3 Research Institutes
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Recombinant Protein Expression System Market Perspective (2017-2028)
2.2 Recombinant Protein Expression System Growth Trends by Region
2.2.1 Recombinant Protein Expression System Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Recombinant Protein Expression System Historic Market Size by Region (2017-2022)
2.2.3 Recombinant Protein Expression System Forecasted Market Size by Region (2023-2028)
2.3 Recombinant Protein Expression System Market Dynamics
2.3.1 Recombinant Protein Expression System Industry Trends
2.3.2 Recombinant Protein Expression System Market Drivers
2.3.3 Recombinant Protein Expression System Market Challenges
2.3.4 Recombinant Protein Expression System Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Recombinant Protein Expression System Players by Revenue
3.1.1 Global Top Recombinant Protein Expression System Players by Revenue (2017-2022)
3.1.2 Global Recombinant Protein Expression System Revenue Market Share by Players (2017-2022)
3.2 Global Recombinant Protein Expression System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Recombinant Protein Expression System Revenue
3.4 Global Recombinant Protein Expression System Market Concentration Ratio
3.4.1 Global Recombinant Protein Expression System Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Recombinant Protein Expression System Revenue in 2021
3.5 Recombinant Protein Expression System Key Players Head office and Area Served
3.6 Key Players Recombinant Protein Expression System Product Solution and Service
3.7 Date of Enter into Recombinant Protein Expression System Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Recombinant Protein Expression System Breakdown Data by Type
4.1 Global Recombinant Protein Expression System Historic Market Size by Type (2017-2022)
4.2 Global Recombinant Protein Expression System Forecasted Market Size by Type (2023-2028)
5 Recombinant Protein Expression System Breakdown Data by Application
5.1 Global Recombinant Protein Expression System Historic Market Size by Application (2017-2022)
5.2 Global Recombinant Protein Expression System Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Recombinant Protein Expression System Market Size (2017-2028)
6.2 North America Recombinant Protein Expression System Market Size by Type
6.2.1 North America Recombinant Protein Expression System Market Size by Type (2017-2022)
6.2.2 North America Recombinant Protein Expression System Market Size by Type (2023-2028)
6.2.3 North America Recombinant Protein Expression System Market Share by Type (2017-2028)
6.3 North America Recombinant Protein Expression System Market Size by Application
6.3.1 North America Recombinant Protein Expression System Market Size by Application (2017-2022)
6.3.2 North America Recombinant Protein Expression System Market Size by Application (2023-2028)
6.3.3 North America Recombinant Protein Expression System Market Share by Application (2017-2028)
6.4 North America Recombinant Protein Expression System Market Size by Country
6.4.1 North America Recombinant Protein Expression System Market Size by Country (2017-2022)
6.4.2 North America Recombinant Protein Expression System Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Recombinant Protein Expression System Market Size (2017-2028)
7.2 Europe Recombinant Protein Expression System Market Size by Type
7.2.1 Europe Recombinant Protein Expression System Market Size by Type (2017-2022)
7.2.2 Europe Recombinant Protein Expression System Market Size by Type (2023-2028)
7.2.3 Europe Recombinant Protein Expression System Market Share by Type (2017-2028)
7.3 Europe Recombinant Protein Expression System Market Size by Application
7.3.1 Europe Recombinant Protein Expression System Market Size by Application (2017-2022)
7.3.2 Europe Recombinant Protein Expression System Market Size by Application (2023-2028)
7.3.3 Europe Recombinant Protein Expression System Market Share by Application (2017-2028)
7.4 Europe Recombinant Protein Expression System Market Size by Country
7.4.1 Europe Recombinant Protein Expression System Market Size by Country (2017-2022)
7.4.2 Europe Recombinant Protein Expression System Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Recombinant Protein Expression System Market Size (2017-2028)
8.2 Asia-Pacific Recombinant Protein Expression System Market Size by Type
8.2.1 Asia-Pacific Recombinant Protein Expression System Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Recombinant Protein Expression System Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Recombinant Protein Expression System Market Share by Type (2017-2028)
8.3 Asia-Pacific Recombinant Protein Expression System Market Size by Application
8.3.1 Asia-Pacific Recombinant Protein Expression System Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Recombinant Protein Expression System Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Recombinant Protein Expression System Market Share by Application (2017-2028)
8.4 Asia-Pacific Recombinant Protein Expression System Market Size by Region
8.4.1 Asia-Pacific Recombinant Protein Expression System Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Recombinant Protein Expression System Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Recombinant Protein Expression System Market Size (2017-2028)
9.2 Latin America Recombinant Protein Expression System Market Size by Type
9.2.1 Latin America Recombinant Protein Expression System Market Size by Type (2017-2022)
9.2.2 Latin America Recombinant Protein Expression System Market Size by Type (2023-2028)
9.2.3 Latin America Recombinant Protein Expression System Market Share by Type (2017-2028)
9.3 Latin America Recombinant Protein Expression System Market Size by Application
9.3.1 Latin America Recombinant Protein Expression System Market Size by Application (2017-2022)
9.3.2 Latin America Recombinant Protein Expression System Market Size by Application (2023-2028)
9.3.3 Latin America Recombinant Protein Expression System Market Share by Application (2017-2028)
9.4 Latin America Recombinant Protein Expression System Market Size by Country
9.4.1 Latin America Recombinant Protein Expression System Market Size by Country (2017-2022)
9.4.2 Latin America Recombinant Protein Expression System Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Recombinant Protein Expression System Market Size (2017-2028)
10.2 Middle East & Africa Recombinant Protein Expression System Market Size by Type
10.2.1 Middle East & Africa Recombinant Protein Expression System Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Recombinant Protein Expression System Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Recombinant Protein Expression System Market Share by Type (2017-2028)
10.3 Middle East & Africa Recombinant Protein Expression System Market Size by Application
10.3.1 Middle East & Africa Recombinant Protein Expression System Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Recombinant Protein Expression System Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Recombinant Protein Expression System Market Share by Application (2017-2028)
10.4 Middle East & Africa Recombinant Protein Expression System Market Size by Country
10.4.1 Middle East & Africa Recombinant Protein Expression System Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Recombinant Protein Expression System Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Thermo Fisher
11.1.1 Thermo Fisher Company Details
11.1.2 Thermo Fisher Business Overview
11.1.3 Thermo Fisher Recombinant Protein Expression System Introduction
11.1.4 Thermo Fisher Revenue in Recombinant Protein Expression System Business (2017-2022)
11.1.5 Thermo Fisher Recent Developments
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Recombinant Protein Expression System Introduction
11.2.4 Merck Revenue in Recombinant Protein Expression System Business (2017-2022)
11.2.5 Merck Recent Developments
11.3 GenScript
11.3.1 GenScript Company Details
11.3.2 GenScript Business Overview
11.3.3 GenScript Recombinant Protein Expression System Introduction
11.3.4 GenScript Revenue in Recombinant Protein Expression System Business (2017-2022)
11.3.5 GenScript Recent Developments
11.4 Agilent
11.4.1 Agilent Company Details
11.4.2 Agilent Business Overview
11.4.3 Agilent Recombinant Protein Expression System Introduction
11.4.4 Agilent Revenue in Recombinant Protein Expression System Business (2017-2022)
11.4.5 Agilent Recent Developments
11.5 Takara Bio
11.5.1 Takara Bio Company Details
11.5.2 Takara Bio Business Overview
11.5.3 Takara Bio Recombinant Protein Expression System Introduction
11.5.4 Takara Bio Revenue in Recombinant Protein Expression System Business (2017-2022)
11.5.5 Takara Bio Recent Developments
11.6 Bio-Rad Laboratories
11.6.1 Bio-Rad Laboratories Company Details
11.6.2 Bio-Rad Laboratories Business Overview
11.6.3 Bio-Rad Laboratories Recombinant Protein Expression System Introduction
11.6.4 Bio-Rad Laboratories Revenue in Recombinant Protein Expression System Business (2017-2022)
11.6.5 Bio-Rad Laboratories Recent Developments
11.7 Qiagen N.V
11.7.1 Qiagen N.V Company Details
11.7.2 Qiagen N.V Business Overview
11.7.3 Qiagen N.V Recombinant Protein Expression System Introduction
11.7.4 Qiagen N.V Revenue in Recombinant Protein Expression System Business (2017-2022)
11.7.5 Qiagen N.V Recent Developments
11.8 Charles River
11.8.1 Charles River Company Details
11.8.2 Charles River Business Overview
11.8.3 Charles River Recombinant Protein Expression System Introduction
11.8.4 Charles River Revenue in Recombinant Protein Expression System Business (2017-2022)
11.8.5 Charles River Recent Developments
11.9 Sartorius
11.9.1 Sartorius Company Details
11.9.2 Sartorius Business Overview
11.9.3 Sartorius Recombinant Protein Expression System Introduction
11.9.4 Sartorius Revenue in Recombinant Protein Expression System Business (2017-2022)
11.9.5 Sartorius Recent Developments
11.10 Corning
11.10.1 Corning Company Details
11.10.2 Corning Business Overview
11.10.3 Corning Recombinant Protein Expression System Introduction
11.10.4 Corning Revenue in Recombinant Protein Expression System Business (2017-2022)
11.10.5 Corning Recent Developments
11.11 FUJIFILM Irvine Scientific
11.11.1 FUJIFILM Irvine Scientific Company Details
11.11.2 FUJIFILM Irvine Scientific Business Overview
11.11.3 FUJIFILM Irvine Scientific Recombinant Protein Expression System Introduction
11.11.4 FUJIFILM Irvine Scientific Revenue in Recombinant Protein Expression System Business (2017-2022)
11.11.5 FUJIFILM Irvine Scientific Recent Developments
11.12 Lonza Group
11.12.1 Lonza Group Company Details
11.12.2 Lonza Group Business Overview
11.12.3 Lonza Group Recombinant Protein Expression System Introduction
11.12.4 Lonza Group Revenue in Recombinant Protein Expression System Business (2017-2022)
11.12.5 Lonza Group Recent Developments
11.13 Bioneer Corporation
11.13.1 Bioneer Corporation Company Details
11.13.2 Bioneer Corporation Business Overview
11.13.3 Bioneer Corporation Recombinant Protein Expression System Introduction
11.13.4 Bioneer Corporation Revenue in Recombinant Protein Expression System Business (2017-2022)
11.13.5 Bioneer Corporation Recent Developments
11.14 Promega
11.14.1 Promega Company Details
11.14.2 Promega Business Overview
11.14.3 Promega Recombinant Protein Expression System Introduction
11.14.4 Promega Revenue in Recombinant Protein Expression System Business (2017-2022)
11.14.5 Promega Recent Developments
11.15 Oxford Expression Technologies
11.15.1 Oxford Expression Technologies Company Details
11.15.2 Oxford Expression Technologies Business Overview
11.15.3 Oxford Expression Technologies Recombinant Protein Expression System Introduction
11.15.4 Oxford Expression Technologies Revenue in Recombinant Protein Expression System Business (2017-2022)
11.15.5 Oxford Expression Technologies Recent Developments
11.16 ProteoGenix
11.16.1 ProteoGenix Company Details
11.16.2 ProteoGenix Business Overview
11.16.3 ProteoGenix Recombinant Protein Expression System Introduction
11.16.4 ProteoGenix Revenue in Recombinant Protein Expression System Business (2017-2022)
11.16.5 ProteoGenix Recent Developments
11.17 Abeomics
11.17.1 Abeomics Company Details
11.17.2 Abeomics Business Overview
11.17.3 Abeomics Recombinant Protein Expression System Introduction
11.17.4 Abeomics Revenue in Recombinant Protein Expression System Business (2017-2022)
11.17.5 Abeomics Recent Developments
11.18 New England Biolabs
11.18.1 New England Biolabs Company Details
11.18.2 New England Biolabs Business Overview
11.18.3 New England Biolabs Recombinant Protein Expression System Introduction
11.18.4 New England Biolabs Revenue in Recombinant Protein Expression System Business (2017-2022)
11.18.5 New England Biolabs Recent Developments
11.19 Promab Biotechnologies
11.19.1 Promab Biotechnologies Company Details
11.19.2 Promab Biotechnologies Business Overview
11.19.3 Promab Biotechnologies Recombinant Protein Expression System Introduction
11.19.4 Promab Biotechnologies Revenue in Recombinant Protein Expression System Business (2017-2022)
11.19.5 Promab Biotechnologies Recent Developments
11.20 Sino Biological
11.20.1 Sino Biological Company Details
11.20.2 Sino Biological Business Overview
11.20.3 Sino Biological Recombinant Protein Expression System Introduction
11.20.4 Sino Biological Revenue in Recombinant Protein Expression System Business (2017-2022)
11.20.5 Sino Biological Recent Developments
11.21 Jena Bioscience
11.21.1 Jena Bioscience Company Details
11.21.2 Jena Bioscience Business Overview
11.21.3 Jena Bioscience Recombinant Protein Expression System Introduction
11.21.4 Jena Bioscience Revenue in Recombinant Protein Expression System Business (2017-2022)
11.21.5 Jena Bioscience Recent Developments
11.22 Lifesensors
11.22.1 Lifesensors Company Details
11.22.2 Lifesensors Business Overview
11.22.3 Lifesensors Recombinant Protein Expression System Introduction
11.22.4 Lifesensors Revenue in Recombinant Protein Expression System Business (2017-2022)
11.22.5 Lifesensors Recent Developments
11.23 Leading biology
11.23.1 Leading biology Company Details
11.23.2 Leading biology Business Overview
11.23.3 Leading biology Recombinant Protein Expression System Introduction
11.23.4 Leading biology Revenue in Recombinant Protein Expression System Business (2017-2022)
11.23.5 Leading biology Recent Developments
11.24 Peak Proteins
11.24.1 Peak Proteins Company Details
11.24.2 Peak Proteins Business Overview
11.24.3 Peak Proteins Recombinant Protein Expression System Introduction
11.24.4 Peak Proteins Revenue in Recombinant Protein Expression System Business (2017-2022)
11.24.5 Peak Proteins Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer